Avesthagen ties up with Chilean biotech firm

Image
Press Trust of India Bangalore
Last Updated : Jan 19 2013 | 11:26 PM IST

Avesthagen Limited,a leading Indian biotechnology firm, has entered into stategic alliance with Uxmal S.A., a Chilean biotechnology firm for promoting research and development of bioactives for commercialisation and use in products like functional foods and healthcare.
 
Avesthagen also announced its international expansion by setting up Avesthagen Latam SpA at the Venture Lab at the Business School of the Universidad Adolfo Ibanez in Penanlolen, Santiago.
 
The two firms would work on bioactives and tissue culture for development of bioinformatic platforms based on Latin American plants, development and commercialisation of functional foods based on bioactives developed by Avestahgen and those from Latin American medicinal plants.
 
It would also work on development of bioactives and tissue culture of a specific plant species for commercial applications and production of bioactives globally. The firms would work on marketing of biosimilars that are in an advanced stage of development at Avesthagen.
 
According Dr Villoo Moarawala Patel, CMD, Avesthagen "We intend to use our domain expertise and knowledge base in furthering research and development related activities for the development of technology and products in agriculture, pharma and food business internationally."

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 20 2009 | 5:30 PM IST

Next Story